NEK Biosciences Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
NEK Biosciences General Information
Description
Developer of regenerative medicine products designed for wound healing in animals. The company offers collagen-based formulations for treating tissue damage, enabling agricultural users to improve animal health and reduce productivity loss.
Contact Information
Corporate Office
- 159 Willoughby Lake Road
- Barton, VT 05822
- United States
Corporate Office
- 159 Willoughby Lake Road
- Barton, VT 05822
- United States
NEK Biosciences Timeline
NEK Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 06-Apr-2026 | Completed | Startup | |||
| 2. Grant | 01-Jan-2025 | Completed | Startup | |||
| 1. Grant | 01-Jan-2024 | $10K | Completed | Startup |
NEK Biosciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LaunchVT | Accelerator/Incubator | |||
| University of Vermont | University |
NEK Biosciences FAQs
-
Where is NEK Biosciences headquartered?
NEK Biosciences is headquartered in Barton, VT.
-
What industry is NEK Biosciences in?
NEK Biosciences’s primary industry is Biotechnology.
-
Is NEK Biosciences a private or public company?
NEK Biosciences is a Private company.
-
What is NEK Biosciences’s current revenue?
The current revenue for NEK Biosciences is .
-
Who are NEK Biosciences’s investors?
LaunchVT and University of Vermont have invested in NEK Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process